Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists - 1 Oct 1997

Jones M W, Kounelis S, Hsu C, Papadaki H, Bakker A, Swalsky P A, Finkelstein S D

Abstract excerpt

The predictive value of p53 and K-ras-2 mutational genotyping in determining tumor aggressiveness and survival in patients with endometrial carcinoma (EC) was retrospectively evaluated using a molecular genotyping approach on fixative treated tissue specimens. Two groups of patients with EC were selected based upon length of survival. Group A consisted of 14 patients that died within 3 years of initial diagnosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Genes, ras

Share to Genotype

Share to Immunohistochemistry

Share to Point Mutation

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9421075
DOI: 10.1097/00004347-199710000-00010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison.PMID 9421075Read ↗

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.Semantic proximity Read ↗

K- ras gene point mutations in human endometrial carcinomas: correlation with clinicopathological features and patients' outcomeSemantic proximity Read ↗

The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancerSemantic proximity Read ↗

A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.Semantic proximity Read ↗

Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.Semantic proximity Read ↗

Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancerSemantic proximity Read ↗

p53 overexpression as a prognostic indicator in endometrial carcinoma.Semantic proximity Read ↗

p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review.Semantic proximity Read ↗

Topographic genotyping of colorectal carcinoma: from a molecular carcinogenesis model to clinical relevance.Semantic proximity Read ↗

p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.Semantic proximity Read ↗

High‐grade endometrial carcinomas – strategies for typingSemantic proximity Read ↗

Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.